黑色素瘤抗原是针对甲基甲瘤的候选疫苗
Akiko Nakamoto1, Haruka Ohashi1, Yuko Tanaka1
1Department of Public Health and Applied Nutrition, Institution of Health Bioscience, The University of Tokushima Graduate School, Tokushima, Tokushima, Japan.
The journal of medical investigation : JMI
|April 23, 2025
概括
一个突变的 Sarcoma Meth A 细胞系被小鼠的 CD8+ T 细胞拒绝. 这种拒绝与黑色素瘤抗原 (MAg) 表达率升高有关,这表明MAg是潜在的癌症疫苗候选人.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- Sarcoma Meth A 是一种在免疫学和瘤学中广泛使用的模型.
- 一个突变细胞系 (甲基A) 在体内表现出排斥,依赖于CD8+ T细胞.
- 无血性和CD8+细胞枯竭的小鼠没有排斥mMeth A细胞,证实了CD8+细胞的需求.
研究的目的:
- 为了研究突变的肉瘤甲基A细胞的排斥机制.
- 为了确定负责免疫排斥的潜在瘤抗原.
- 评估黑色素瘤抗原 (MAg) 作为针对肉瘤甲状腺瘤的候选疫苗.
主要方法:
- 在BALB/c小鼠的体内皮下挑战中,使用Meth A和mMeth A细胞系.
- 利用无细胞和CD8+细胞枯竭的小鼠来评估免疫细胞的参与.
- 微阵列和定量基因表达分析以识别mMeth A.中的高基因.
- 构建MAg基因序列和通过肌肉内注射免疫的表达载体.
主要成果:
- CD8+ T 细胞对于排斥mMeth A 细胞至关重要.
- 黑色素瘤抗原 (MAg) 在mMeth A中表达显著增加 (100倍),与Meth A相比.
- 用表达Mag 788-1257基因的等离子体进行免疫接种,可以防止体内Meth A挑战.
- 在用MAg等离子体免疫的小鼠中,瘤体积和生存率有所改善.
结论:
- 黑色素瘤抗原 (MAg) 在 Sarcoma Meth A. 的免疫排斥中发挥着关键作用.
- MAg是一种有前途的疫苗候选抗原,用于开发针对肉瘤甲型A瘤的治疗策略.
- CD8+ T细胞介导的免疫对于控制肉瘤Meth A的生长至关重要.
相关概念视频
Cancer Vaccines
238
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
238
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
Skin Cancer
2.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
2.9K


